Scott D. Grimes - 01 Apr 2022 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role: Director
Signature: /s/ Kirk Somers, Attorney-in-Fact
Issuer symbol: CDLX
Transactions as of: 01 Apr 2022
Net transactions value: -$342,176
Form type: 4
Filing time: 05 Apr 2022, 16:55:06 UTC
Previous filing: 24 Mar 2022
Next filing: 07 Apr 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDLX	Common Stock	Options Exercise	$0	+14,920	+6.9%	$0.000000	230,608	01 Apr 2022	Direct	F1
transaction	CDLX	Common Stock	Sale	$141,000	-2,500	-1.1%	$56.40	228,108	04 Apr 2022	Direct	F2, F3
transaction	CDLX	Common Stock	Sale	$177,940	-3,100	-1.4%	$57.40	225,008	04 Apr 2022	Direct	F2, F4
transaction	CDLX	Common Stock	Sale	$23,236	-400	-0.18%	$58.09	224,608	04 Apr 2022	Direct	F2, F5
holding	CDLX	Common Stock						53,112	01 Apr 2022	See Footnote	F6
holding	CDLX	Common Stock						55,832	01 Apr 2022	See Footnote	F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDLX	Restricted Stock Units	Options Exercise	$0	-14,920	-33%	$0.000000	29,840	01 Apr 2022	Common Stock	14,920		Direct	F8, F9

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
F2	These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 12, 2020, as amended September 15, 2021.
F3	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $55.91 to $56.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4.
F4	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $56.93 to $57.90, inclusive.
F5	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $58.05 to $58.17, inclusive.
F6	The reportable securities are held by the 2013 Scott Grimes GRAT UAD.
F7	The reportable securities are held by the UTMA Custodial account fbo Pierce Grimes.
F8	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F9	The RSUs shall vest in equal amounts annually over four years on the anniversary of the date of grant, provided that the Reporting Person remains employed by the Issuer on such vesting date.